|
The progress of President Barack Obama's health care plans in the United States is unlikely to significantly add to the company's sales there, he said. China, meanwhile, saw sales growth of 23 percent during the quarter, the highest increase worldwide. Novartis has resumed production of some drugs at its plant in Lincoln, Nebraska, which was hit by quality control problems late last year. The suspension and remediation efforts have so far cost Novartis $490 million. Jimenez said the Basel-based company isn't looking for major acquisitions at the moment but would consider bolt-on purchases to its existing portfolio.
Copyright 2012 The Associated
Press. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Community |
Perspectives
|
Law & Courts |
Leisure Time
|
Spiritual Life |
Health & Fitness |
Teen Scene
Calendar
|
Letters to the Editor